EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
May 31, 2026 -0.3729
February 28, 2026 -0.4358
November 30, 2025 -0.4539
August 31, 2025 0.0008
May 31, 2025 -0.6064
February 28, 2025 -0.485
November 30, 2024 -0.4439
August 31, 2024 -0.0782
May 31, 2024 -0.0845
February 29, 2024 -0.114
November 30, 2023 -0.0896
August 31, 2023 -0.0673
May 31, 2023 -0.1065
February 28, 2023 -0.1224
November 30, 2022 -0.9668
August 31, 2022 -0.1582
May 31, 2022 -0.1367
February 28, 2022 -0.0081
November 30, 2021 -0.0894
August 31, 2021 -0.1241
May 31, 2021 -1.112
February 28, 2021 -1.428
November 30, 2020 -1.169
August 31, 2020 -1.289
May 31, 2020 -0.0426
Date Value
February 29, 2020 -0.0877
November 30, 2019 -0.0494
August 31, 2019 -0.052
May 31, 2019 -0.0832
February 28, 2019 -0.0728
November 30, 2018 -0.0527
August 31, 2018 -0.05
May 31, 2018 -0.08
February 28, 2018 -0.04
November 30, 2017 -0.03
August 31, 2017 -0.02
May 31, 2017 -0.04
February 28, 2017 -0.04
November 30, 2016 -0.02
August 31, 2016 -0.01
May 31, 2016 -0.16
February 29, 2016 -0.02
November 30, 2015 -0.01
August 31, 2015 -0.01
May 31, 2015 0.0321
February 28, 2015 -0.02
November 30, 2014 -0.03
August 31, 2014 -0.03
May 31, 2014 0.0224
February 28, 2014 0.0034

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Univec, Inc. -0.0001
Lantheus Holdings, Inc. 1.111
Zomedica Corp. -0.0038
IDEXX Laboratories, Inc. 4.267
Neogen Corp. -0.0519